Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers
Condition(s) studied
Investigational drug(s) / intervention(s)
empathy and compassion training: A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises
Study summary
The goal of this clinical trial is to improve quality of life in Parkinson's Disease (PD) patients by increasing their empathy and their (self-)compassion. The main question it aims to answer is:
Does the level of quality of life in PD patients and caregivers improve after empathy/(self-)compassion training?
Participants will be delivered a 6-week empathy and compassion training (mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion) and will also be asked to answer questionnaires before and after the training
Eligibility
Primary outcome measure(s)
- PD patients quality of life improvement — from baseline to the end of intervention (6weeks)
the change (no min / max values foreseen) in the level of quality of life in PD patients as measured by the Parkinson's Disease Questionnaire (PDQ-8), which assesses 8 domains of quality of life: mobility, activities of daily of living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort; higher scores indicate a worse quality of life
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Istituto di Neuroscienze Cliniche della Svizzera Italiana, EOC | Lugano | Switzerland | Recruiting |
More Alain Kaelin trials in Switzerland
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07097298 on ClinicalTrials.gov ↗ ← All trials in Switzerland